Total Payments
$5,066
2024 Payments
$756.57
Companies
30
Transactions
302
Payment Breakdown by Category
Food & Beverage$4,598 (90.8%)
Travel$268.85 (5.3%)
Education$198.68 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,598 | 296 | 90.8% |
| Travel and Lodging | $268.85 | 1 | 5.3% |
| Education | $198.68 | 5 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neuronetics, Inc. | $681.89 | 14 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $541.16 | 45 | $0 (2024) |
| Lundbeck LLC | $378.08 | 21 | $0 (2024) |
| Allergan, Inc. | $377.45 | 19 | $0 (2020) |
| Shire North American Group Inc | $361.71 | 26 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $353.12 | 44 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $339.57 | 15 | $0 (2024) |
| ITI, Inc. | $219.19 | 17 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $201.97 | 8 | $0 (2024) |
| Corium, LLC | $201.24 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $756.57 | 41 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($146.16) |
| 2023 | $707.97 | 45 | ITI, Inc. ($149.44) |
| 2022 | $347.63 | 16 | Neuronetics, Inc. ($71.08) |
| 2021 | $111.02 | 5 | ITI, Inc. ($46.91) |
| 2020 | $133.61 | 8 | Otsuka America Pharmaceutical, Inc. ($37.38) |
| 2019 | $1,386 | 69 | Neuronetics, Inc. ($535.65) |
| 2018 | $764.91 | 53 | Otsuka America Pharmaceutical, Inc. ($143.65) |
| 2017 | $857.51 | 65 | Shire North American Group Inc ($243.24) |
All Payment Transactions
302 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.73 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: ADHD | ||||||
| 10/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Neuropsychiatry | ||||||
| 10/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $31.20 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: ADHD | ||||||
| 09/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Neurology | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: PSYCHIATRY | ||||||
| 07/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: CNS | ||||||
| 06/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: PSYCHIATRY | ||||||
| 06/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Neuroscience | ||||||
| 05/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Central Nervous System | ||||||
| 05/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 04/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $2.53 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: PSYCHIATRY | ||||||
| 03/26/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: ADHD | ||||||
About Dr. Robert Devney, MD
Dr. Robert Devney, MD is a Child & Adolescent Psychiatry healthcare provider based in Bothell, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770668576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Devney, MD has received a total of $5,066 in payments from pharmaceutical and medical device companies, with $756.57 received in 2024. These payments were reported across 302 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,598).
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Psychiatry
- Location Bothell, WA
- Active Since 10/27/2006
- Last Updated 11/24/2023
- Taxonomy Code 2084P0804X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770668576
Products in Payments
- REXULTI (Drug) $789.78
- NEUROSTAR TMS THERAPY (Device) $578.68
- VRAYLAR (Drug) $537.28
- CAPLYTA (Drug) $365.35
- LATUDA (Drug) $353.12
- VYVANSE (Drug) $279.37
- AUSTEDO (Drug) $182.87
- INGREZZA (Drug) $149.01
- Azstarys (Drug) $136.17
- Qelbree (Drug) $123.81
- Trintellix (Drug) $114.34
- NEUROSTAR TMS THERAPY SYSTEM (Device) $103.21
- MYDAYIS (Drug) $95.74
- ARISTADA (Drug) $79.90
- TRINTELLIX (Drug) $78.31
- QELBREE (Drug) $78.16
- NUEDEXTA (Drug) $76.65
- Dyanavel XR (Drug) $66.89
- AZSTARYS (Drug) $65.07
- APLENZIN (Drug) $62.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.